Ruxolitinib for treatment of refractory hemophagocytic lymphohistiocytosis
Larisa Broglie(Morgan Stanley Children's Hospital), Julie‐An Talano(Dana-Farber Cancer Institute), Sridhar Rao(Medical College of Wisconsin), David M. Margolis(University of North Carolina at Chapel Hill), Rachel Phelan(Children's Hospital of Wisconsin), Lauren Pommert(Cincinnati Children's Hospital Medical Center), Monica S. Thakar(Fred Hutch Cancer Center)
Cited by 128
Related Papers
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
|Nature|2012|1.2k
The Challenge of Finding a Cure for HIV Infection
|Science|2009|850
Current Use of and Trends in Hematopoietic Cell Transplantation in the United States
|Transplantation and Cellular Therapy|2020|718
Allogeneic Human Mesenchymal Stem Cell Therapy (Remestemcel-L, Prochymal) as a Rescue Agent for Severe Refractory Acute Graft-versus-Host Disease in Pediatric Patients
|Transplantation and Cellular Therapy|2013|248